Overview

Buprenorphine Dose Alteration Study - 1

Status:
Completed

Trial end date:
2001-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.

Phase:

Phase 1

Details

Lead Sponsor:

University of Vermont

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Buprenorphine